EUVIMEDEUVIMED entdecken
Crossref

INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib

Na Qu, Gang Wang, Yue Su, Bo Chen, Duanfang Zhou, Yuanli Wu, Lie Yuan, Manjialan Yin, Mingpu Liu, Yang Peng, Weiying Zhou

Biochemical Pharmacology · 2024

DOI: 10.1016/j.bcp.2024.116347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von Na Qu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Drug Metabolism, …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms, Epithelial-Mesenchymal Transition, Lapatinib. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human epidermal growth factor receptor 2 positive (HER2+) breast cancer (BC) tends to metastasize and has a bad prognosis due to its high malignancy and rapid progression. Inositol polyphosphate 4-phosphatase isoenzymes type II (INPP4B) plays unequal roles in the development of various cancers. However, the function of INPP4B in HER2+ BC has not been elucidated. Here we found that INPP4B expression was significantly lower in HER2+ BC and positively correlated with the prognosis by bioinformatics and tissue immunofluorescence analyses. Overexpression of INPP4B inhibited cell proliferation, migration, and growth of xenografts in HER2+ BC cells. Conversely, depletion of INPP4B reversed these effects and activated the PDK1/AKT and Wnt/β-catenin signaling pathways to promote epithelial-mesenchymal transition (EMT) progression. Moreover, INPP4B overexpression blocked epidermal growth factor (EGF) -induced cell proliferation, migration and EMT progression, whereas INPP4B depletion antagonized HER2 depletion in reduction of cell proliferation and migration of HER2+ BC cells. Additionally, Lapatinib (LAP) inhibited HER2+ BC cell survival, proliferation and migration, and its effect was further enhanced by overexpression of INPP4B. In summary, our results illustrate that INPP4B suppresses HER2+ BC growth, migration and EMT, and its expression level affects patient outcome, further providing new insights into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBreast NeoplasmsEpithelial-Mesenchymal TransitionLapatinibPhosphoric Monoester HydrolasesErb-b2 Receptor Tyrosine KinasesAnimalsFemaleHumansMiceCell Line, TumorCell MovementCell ProliferationMice, Inbred BALB CMice, NudeXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Breast cancerEMTHER2+INPP4BLapatinib

Substanzen

Antineoplastic AgentsLapatinibPhosphoric Monoester HydrolasesErb-b2 Receptor Tyrosine KinasesERBB2 protein, humanphosphatidylinositol-3,4-bisphosphate 4-phosphatase

Autor:innen und Institutionen

  • Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing Medical University, Chongqing 400016, China; Key Laboratory…
  • Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: pengyangpoop6@qq.com.

Zitieren

APA

Qu, N., Wang, G., Su, Y., Chen, B., Zhou, D., Wu, Y., Yuan, L., Yin, M., Liu, M., Peng, Y., & Zhou, W. (2024). INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116347

Vancouver

Qu N, Wang G, Su Y, Chen B, Zhou D, Wu Y, et al. INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116347

BibTeX
@article{Qu2024,
  author = {Qu, Na and Wang, Gang and Su, Yue and Chen, Bo and Zhou, Duanfang and Wu, Yuanli and Yuan, Lie and Yin, Manjialan and Liu, Mingpu and Peng, Yang and Zhou, Weiying},
  title = {INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib},
  journal = {Biochemical Pharmacology},
  year = {2024},
  doi = {10.1016/j.bcp.2024.116347}
}
Kostenlos starten →